Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES

Breast Cancer Research and Treatment ◽

10.1007/s10549-021-06173-z ◽

2021 ◽

Author(s):

Young-Hyuck Im ◽

Bulent Karabulut ◽

Keun Seok Lee ◽

Byeong-Woo Park ◽

Aditya Adhav ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Postmenopausal Women ◽

Locally Advanced ◽

Metastatic Breast ◽

Safety And Efficacy

Download Full-text

Phase II, 3-arm study of CCI-779 in combination with letrozole in postmenopausal women with locally advanced or metastatic breast cancer: preliminary results

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.544 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 544-544 ◽

Author(s):

J. Baselga ◽

P. Fumoleau ◽

M. Gil ◽

R. Colomer ◽

H. Roche ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Postmenopausal Women ◽

Phase Ii ◽

Locally Advanced ◽

Metastatic Breast ◽

Preliminary Results

Download Full-text

Randomized 3-arm, phase 2 study of temsirolimus (CCI-779) in combination with letrozole in postmenopausal women with locally advanced or metastatic breast cancer

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.564 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 564-564 ◽

Author(s):

J. T. Carpenter ◽

H. Roché ◽

M. Campone ◽

R. Colomer ◽

A. Jagiello-Gruszfeld ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Postmenopausal Women ◽

Locally Advanced ◽

Metastatic Breast ◽

Phase 2 ◽

Download Full-text

A Phase II study to assess the safety and efficacy of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER positive locally advanced or metastatic breast cancer patients (IRIS) – Trial Results.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.549 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 549-549 ◽

Author(s):

Carlo Palmieri ◽

Robert C. Stein ◽

Xinxue Liu ◽

Emma Hudson ◽

Sadie Reed ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Phase Ii Study ◽

Locally Advanced ◽

Metastatic Breast ◽

Steroid Sulfatase ◽

Breast Cancer Patients ◽

Safety And Efficacy ◽

Download Full-text

A Randomised Trial of Sequential Aromatase Inhibitors (AI) in Postmenopausal Women with Locally Advanced or Metastatic Breast Cancer. The SAINT Trial

http://isrctn.org/> ◽

10.1186/isrctn99515843 ◽

2012 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Postmenopausal Women ◽

Aromatase Inhibitors ◽

Randomised Trial ◽

Locally Advanced ◽

Metastatic Breast

Download Full-text

PCN132 ECONOMIC EVALUATION AND BUDGET IMPACT OF FULVESTRANT (FASLODEX®) IN THE TREATMENT OF LOCALLY ADVANCED OR METASTATIC BREAST CANCER IN POSTMENOPAUSAL WOMEN WHO HAVE NOT RECEIVED PRIOR ENDOCRINE THERAPY FROM THE PERSPECTIVE OF THE PUBLIC HEALTHCARE SYSTEM IN MEXICO

Value in Health ◽

10.1016/j.jval.2019.04.256 ◽

2019 ◽

Vol 22 ◽

pp. S81

Author(s):

F. Carlos ◽

J. Guzmán ◽

M. Naranjo ◽

M. Carmona

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Economic Evaluation ◽

Postmenopausal Women ◽

Endocrine Therapy ◽

Budget Impact ◽

Locally Advanced ◽

Metastatic Breast ◽

Public Healthcare ◽

Download Full-text

Interim Safety and Efficacy of Pertuzumab, Trastuzumab and Vinorelbine for First-Line (1L) Treatment of Patients (Pts) with Her2-Positive Locally Advanced or Metastatic Breast Cancer (Mbc)

Annals of Oncology ◽

10.1093/annonc/mdu329.11 ◽

2014 ◽

Vol 25 ◽

pp. iv120 ◽

Author(s):

M. Andersson ◽

J.M. Lopez-Vega ◽

T. Petit ◽

C. Zamagni ◽

U. Freudensprung ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Locally Advanced ◽

Metastatic Breast ◽

Her2 Positive ◽

Safety And Efficacy

Download Full-text

Phase II, 3-arm study of CCI-779 in combination with letrozole in postmenopausal women with locally advanced or metastatic breast cancer: preliminary results

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.544 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 544-544 ◽

Author(s):

J. Baselga ◽

P. Fumoleau ◽

M. Gil ◽

R. Colomer ◽

H. Roche ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Postmenopausal Women ◽

Phase Ii ◽

Locally Advanced ◽

Metastatic Breast ◽

Preliminary Results

Download Full-text

Abstract OT2-3-08: Phase III randomized study of the oral pan-PI3K inhibitor BKM120 with fulvestrant in postmenopausal women with HR+/HER2– locally advanced or metastatic breast cancer, treated with aromatase inhibitor, and progressed on or after mTOR inhibitor-based treatment – BELLE-3

10.1158/0008-5472.sabcs12-ot2-3-08 ◽

2012 ◽

Author(s):

A Di Leo ◽

C Germa ◽

D Weber ◽

E Di Tomaso ◽

B Dharan ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Mtor Inhibitor ◽

Randomized Study ◽

Locally Advanced ◽

Metastatic Breast ◽

Pi3k Inhibitor ◽

Download Full-text

Phase 1b/2 safety and efficacy of TAK-228 (MLN0128), plus exemestane (E) or fulvestrant (F) in postmenopausal women with ER + /HER2- metastatic breast cancer (MBC)

Annals of Oncology ◽

10.1093/annonc/mdw365.56 ◽

2016 ◽

Vol 27 ◽

pp. vi86 ◽

Author(s):

J. Diamond ◽

V.F. Borges ◽

P. Kabos ◽

E. Krill-Jackson ◽

R. Graham ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Postmenopausal Women ◽

Metastatic Breast ◽

Safety And Efficacy ◽

Download Full-text

Safety and efficacy of the addition of pertuzumab to T-DM1 ± taxane in patients with HER2-positive, locally advanced or metastatic breast cancer: a pooled analysis

Drug Design Development and Therapy ◽

10.2147/dddt.s149032 ◽

2017 ◽

Vol Volume 11 ◽

pp. 3235-3244 ◽

Author(s):

Jing Zhang ◽

Jinying Li ◽

Chenjing Zhu ◽

Yanlin Song ◽

Fan Xia ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Locally Advanced ◽

Metastatic Breast ◽

Pooled Analysis ◽

Her2 Positive ◽

Safety And Efficacy

Download Full-text